Is the Hemocytometer Obsolete for Body Fluid Cell Counting?
Linda M. Sandhaus
Abstract
Linda M. Sandhaus
Abstract
Automated body fluid (BF) cell counts performed on hematology analyzers have been steadily replacing manual hemocytometer (counting chamber) cell counts in clinical laboratories. Hematology analyzers with dedicated BF modes are capable of producing an RBC count, total nucleated cell (TNC) count, WBC count, and a limited WBC differential count. Distinguishing TNCs from WBCs is particularly useful for serous fluids, where body cavity lining cells may be present in significant numbers and can interfere with the accuracy of manual WBC counts if they are not excluded. Although lining cells rarely interfere with WBC counts in cerebrospinal fluid (CSF), the extremely low CSF WBC concentrations relative to blood have limited the use of automated hematology analyzers for CSF cell counts. Achieving the accuracy and precision required to reliably distinguish pathologic CSF specimens from normal samples has posed a challenge to automated hematology analyzer manufacturers. In this issue, Fleming et al1 present an evaluation of a new high-sensitivity analysis (hsA) BF mode on the Sysmex XN hematology analyzer (Sysmex, Kobe, Japan) for CSF cell counts. The hsA BF mode is not yet commercially available but can be accessed for research purposes on the XN analyzers. Their results suggest that Sysmex has met the challenge of automated enumeration of WBCs and RBCs in CSF samples.
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Automated body fluid (BF) cell counts performed on hematology analyzers have been steadily replacing manual hemocytometer (counting chamber) cell counts in clinical laboratories. Hematology analyzers with dedicated BF modes are capable of producing an RBC count, total nucleated cell (TNC) count, WBC count, and a limited WBC differential count. Distinguishing TNCs from WBCs is particularly useful for serous fluids, where body cavity lining cells may be present in significant numbers and can interfere with the accuracy of manual WBC counts if they are not excluded. Although lining cells rarely interfere with WBC counts in cerebrospinal fluid (CSF), the extremely low CSF WBC concentrations relative to blood have limited the use of automated hematology analyzers for CSF cell counts. Achieving the accuracy and precision required to reliably distinguish pathologic CSF specimens from normal samples has posed a challenge to automated hematology analyzer manufacturers. In this issue, Fleming et al1 present an evaluation of a new high-sensitivity analysis (hsA) BF mode on the Sysmex XN hematology analyzer (Sysmex, Kobe, Japan) for CSF cell counts. The hsA BF mode is not yet commercially available but can be accessed for research purposes on the XN analyzers. Their results suggest that Sysmex has met the challenge of automated enumeration of WBCs and RBCs in CSF samples.
Key concepts: Hematology analyzer, Hemocytometer, Cell counting, Hematology, Medicine, Body fluid, Pathology, Blood cell